Tropical and Vector-Borne Diseases Research Group

Prof. Dr. Emrah Ruh

Researchers: Prof. Dr. Tamer Şanlıdağ, Prof. Dr. Kaya Süer, Prof. Dr. Umut Gazi, Prof. Dr. Ayşegül Taylan Özkan (Cyprus International University), Prof. Dr. Ahmet Özbilgin (Manisa Celal Bayar University), Assist. Prof. Dr. Ayşe Seyer, Assist. Prof. Dr. Emrah Güler (European University of Lefke)

Tropical diseases are primarily observed in tropical regions and are closely associated with poverty, inadequate healthcare services, and adverse living conditions; however, due to factors such as migration, international travel, and climate change, their distribution has extended beyond tropical and subtropical areas. A significant proportion of these diseases are transmitted through vectors and pose serious public health challenges, particularly in developing countries. The climatic conditions in Cyprus, located in the eastern part of the Mediterranean region, provide a favorable environment for various vector-borne diseases. Therefore, scientific studies focused on the surveillance, diagnosis, and control of tropical and vector-borne diseases are of great importance.

Our mission is to examine the distribution of tropical and vector-borne diseases observed in our country and the surrounding region, to identify the causative microorganisms using microbiological and molecular methods, and to generate scientific data related to these diseases that threaten public health. Our vision is to contribute to the establishment of a competent research infrastructure at the national and regional levels through scientific studies on the surveillance, early diagnosis, and control of tropical and vector-borne diseases, and to support the development of effective infection control programs based on the scientific evidence obtained.

Within the scope of this research group, it is aimed to determine the distribution of tropical and vector-borne diseases in our country, to identify the causative microorganisms using microbiological and molecular methods, to investigate the presence of antibodies through serological methods, and to determine potential risk factors associated with these diseases. Furthermore, the research findings will be shared with relevant health authorities to support the development of infection control programs.